Quoin Pharmaceuticals Ltd DRC (QNRX) had the highest return in 2016 by a US stock in the Biotechnology Industry, returning 1,902.8%.
| ASSET | YEAR | % RETURN |
|---|---|---|
Quoin Pharmaceuticals Ltd DRC (QNRX) | 2016 | 1,902.78% |
Biocardia (BCDA) | 2016 | 1,442.86% |
Corbus Pharmaceuticals (CRBP) | 2016 | 409.04% |
PharmaCyte Biotech (PMCB) | 2016 | 200.81% |
Exelixis (EXEL) | 2016 | 171.09% |
ProMIS Neurosciences (PMN) | 2016 | 150% |
Mind Medicine (MNMD) | 2016 | 144.5% |
Biovie (BIVI) | 2016 | 143.8% |
Merus (MRUS) | 2016 | 116.51% |
Anixa Biosciences (ANIX) | 2016 | 100.74% |
Minerva Neurosciences (NERV) | 2016 | 95.83% |
Lexaria Bioscience (LEXX) | 2016 | 87.88% |
Xencor (XNCR) | 2016 | 86.93% |
Protagonist Therapeutics (PTGX) | 2016 | 83.25% |
Vanda Pharmaceuticals (VNDA) | 2016 | 75.47% |
Altimmune (ALT) | 2016 | 74.73% |
Evotec SE ADR (EVO) | 2016 | 73.19% |
MediciNova (MNOV) | 2016 | 67.5% |
Amarin (AMRN) | 2016 | 65.59% |
Matinas BioPharma (MTNB) | 2016 | 64.71% |
Assembly Biosciences (ASMB) | 2016 | 62% |
Checkpoint Therapeutics (CKPT) | 2016 | 60% |
Qualigen Therapeutics (QLGN) | 2016 | 59.41% |
Theratechnologies (THTX) | 2016 | 55.22% |
Indivior PLC Ordinary Shares (INDV) | 2016 | 50.78% |
